Literature DB >> 22171602

Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions.

Matthias Naumer1, Ying Ying, Stefan Michelfelder, Antje Reuter, Martin Trepel, Oliver J Müller, Jürgen A Kleinschmidt.   

Abstract

Libraries based on the insertion of random peptide ligands into the capsid of adeno-associated virus type 2 (AAV2) have been widely used to improve the efficiency and selectivity of the AAV vector system. However, so far only libraries of 7-mer peptide ligands have been inserted at one well-characterized capsid position. Here, we expanded the combinatorial AAV2 display system to a panel of novel AAV libraries, displaying peptides of 5, 7, 12, 19, or 26 amino acids in length at capsid position 588 or displaying 7-mer peptides at position 453, the most prominently exposed region of the viral capsid. Library selections on two unrelated cell types-human coronary artery endothelial cells and rat cardiomyoblasts-revealed the isolation of cell type-characteristic peptides of different lengths mediating strongly improved target-cell transduction, except for the 26-mer peptide ligands. Characterization of vector selectivity by transduction of nontarget cells and comparative gene-transduction analysis using a panel of 44 human tumor cell lines revealed that insertion of different-length peptides allows targeting of distinct cellular receptors for cell entry with similar efficiency, but with different selectivity. The application of such novel AAV2 libraries broadens the spectrum of targetable receptors by capsid-modified AAV vectors and provides the opportunity to choose the best suited targeting ligand for a certain application from a number of different candidates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22171602     DOI: 10.1089/hum.2011.139

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  5 in total

1.  Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy.

Authors:  Jessica Sallach; Giovanni Di Pasquale; Fernando Larcher; Nadine Niehoff; Matthias Rübsam; Anke Huber; Jay Chiorini; David Almarza; Sabine A Eming; Hikmet Ulus; Stephen Nishimura; Ulrich T Hacker; Michael Hallek; Carien M Niessen; Hildegard Büning
Journal:  Mol Ther       Date:  2014-01-28       Impact factor: 11.454

2.  Optimization of design and production strategies for novel adeno-associated viral display peptide libraries.

Authors:  J Körbelin; A Hunger; M Alawi; T Sieber; M Binder; M Trepel
Journal:  Gene Ther       Date:  2017-07-13       Impact factor: 5.250

3.  Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer.

Authors:  Robert C Münch; Hanna Janicki; Iris Völker; Anke Rasbach; Michael Hallek; Hildegard Büning; Christian J Buchholz
Journal:  Mol Ther       Date:  2012-09-11       Impact factor: 11.454

4.  Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.

Authors:  Karen Nieto; Margit Weghofer; Peter Sehr; Mirko Ritter; Sebastian Sedlmeier; Balasubramanyam Karanam; Hanna Seitz; Martin Müller; Markus Kellner; Markus Hörer; Uwe Michaelis; Richard B S Roden; Lutz Gissmann; Jürgen A Kleinschmidt
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

5.  Biomathematical description of synthetic peptide libraries.

Authors:  Timo Sieber; Eric Hare; Heike Hofmann; Martin Trepel
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.